These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18760875)

  • 1. Regulation of p53R2 and its role as potential target for cancer therapy.
    Wang X; Zhenchuk A; Wiman KG; Albertioni F
    Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
    Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally dependent redox property of ribonucleotide reductase subunit p53R2.
    Xue L; Zhou B; Liu X; Wang T; Shih J; Qi C; Heung Y; Yen Y
    Cancer Res; 2006 Feb; 66(4):1900-5. PubMed ID: 16488986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
    Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox property of ribonucleotide reductase small subunit M2 and p53R2.
    Liu X; Xue L; Yen Y
    Methods Mol Biol; 2008; 477():195-206. PubMed ID: 19082948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
    Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
    J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
    Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
    Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
    Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
    Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
    Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
    Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt and p53R2, partners that dictate the progression and invasiveness of cancer.
    Yousefi B; Samadi N; Ahmadi Y
    DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.
    Bourdon A; Minai L; Serre V; Jais JP; Sarzi E; Aubert S; Chrétien D; de Lonlay P; Paquis-Flucklinger V; Arakawa H; Nakamura Y; Munnich A; Rötig A
    Nat Genet; 2007 Jun; 39(6):776-80. PubMed ID: 17486094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.
    Yousefi B; Rahmati M; Ahmadi Y
    Life Sci; 2014 Mar; 99(1-2):14-7. PubMed ID: 24486301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
    Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
    Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
    Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
    Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.
    Wang X; Liu X; Xue L; Zhang K; Kuo ML; Hu S; Zhou B; Ann D; Zhang S; Yen Y
    Biochem Biophys Res Commun; 2011 Jun; 410(1):102-7. PubMed ID: 21640705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genotoxicity test system based on p53R2 gene expression in human cells: assessment of its reactivity to various classes of genotoxic chemicals.
    Ohno K; Ishihata K; Tanaka-Azuma Y; Yamada T
    Mutat Res; 2008 Oct; 656(1-2):27-35. PubMed ID: 18674635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase.
    Yen Y; Chu B; Yen C; Shih J; Zhou B
    Adv Enzyme Regul; 2006; 46():235-47. PubMed ID: 16846634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.